• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Hind 肢肌肉萎缩先于大脑神经元变性在 G93A-SOD1 肌萎缩侧索硬化症小鼠模型:一项纵向 MRI 研究。

Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: a longitudinal MRI study.

机构信息

Department of Neurology IV, Neuromuscular Diseases and Neuroimmunology, Fondazione Istituto Neurologico Carlo Besta, Milan, 20133, Italy.

出版信息

Exp Neurol. 2011 Sep;231(1):30-7. doi: 10.1016/j.expneurol.2011.05.007. Epub 2011 May 14.

DOI:10.1016/j.expneurol.2011.05.007
PMID:21620832
Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive, fatal, neurodegenerative disorder caused by the degeneration of motor neurons in the CNS, which results in complete paralysis of skeletal muscles. Recent experimental studies have suggested that the disease could initiate in skeletal muscle, rather than in the motor neurons. To establish the timeframe of motor neuron degeneration in relation to muscle atrophy in motor neuron disease, we have used MRI to monitor changes throughout disease in brain and skeletal muscle of G93A-SOD1 mice, a purported model of ALS. Longitudinal MRI examination of the same animals indicated that muscle volume in the G93A-SOD1 mice was significantly reduced from as early as week 8 of life, 4 weeks prior to clinical onset. Progressive muscle atrophy from week 8 onwards was confirmed by histological analysis. In contrast, brain MRI indicated that neurodegeneration occurs later in G93A-SOD1 mice, with hyperintensity MRI signals detected only at weeks 10-18. Neurodegenerative changes were observed only in the motor nuclei areas of the brainstem; MRI changes indicative of neurodegeneration were not detected in the motor cortex where first motor neurons originate, even at the late disease stage. This longitudinal MRI study establishes unequivocally that, in the experimental murine model of ALS, muscle degeneration occurs before any evidence of neurodegeneration and clinical signs, supporting the postulate that motor neuron disease can initiate from muscle damage and result from retrograde dying-back of the motor neurons.

摘要

肌萎缩侧索硬化症(ALS)是一种渐进性、致命的神经退行性疾病,由中枢神经系统运动神经元的退化引起,导致骨骼肌完全瘫痪。最近的实验研究表明,这种疾病可能起源于骨骼肌,而不是运动神经元。为了确定运动神经元退行性变与运动神经元疾病中肌肉萎缩的时间关系,我们使用 MRI 监测 G93A-SOD1 小鼠(ALS 的一种假定模型)大脑和骨骼肌中疾病过程中的变化。对同一动物进行的纵向 MRI 检查表明,G93A-SOD1 小鼠的肌肉体积早在生命的第 8 周就明显减少,比临床发病提前 4 周。组织学分析证实,从第 8 周开始进行性肌肉萎缩。相比之下,脑 MRI 表明 G93A-SOD1 小鼠中的神经退行性变发生得更晚,只有在第 10-18 周才能检测到高信号 MRI 信号。在脑桥的运动核区观察到神经退行性改变;在运动皮层(第一运动神经元起源的地方)没有检测到提示神经退行性变的 MRI 改变,即使在疾病晚期也是如此。这项纵向 MRI 研究明确表明,在 ALS 的实验性小鼠模型中,肌肉退化发生在任何神经退行性变和临床症状出现之前,支持运动神经元疾病可以从肌肉损伤开始并由运动神经元逆行死亡的假设。

相似文献

1
Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: a longitudinal MRI study.Hind 肢肌肉萎缩先于大脑神经元变性在 G93A-SOD1 肌萎缩侧索硬化症小鼠模型:一项纵向 MRI 研究。
Exp Neurol. 2011 Sep;231(1):30-7. doi: 10.1016/j.expneurol.2011.05.007. Epub 2011 May 14.
2
Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.在肌萎缩侧索硬化症的SOD1(G93A)小鼠模型中,轴突退化、远端侧支分支和神经肌肉接头结构改变在症状出现之前就已发生。
J Chem Neuroanat. 2016 Oct;76(Pt A):35-47. doi: 10.1016/j.jchemneu.2016.03.003. Epub 2016 Mar 30.
3
AAV-NRIP gene therapy ameliorates motor neuron degeneration and muscle atrophy in ALS model mice.腺相关病毒-核受体相互作用蛋白基因疗法改善了肌萎缩侧索硬化症模型小鼠的运动神经元变性和肌肉萎缩。
Skelet Muscle. 2024 Jul 24;14(1):17. doi: 10.1186/s13395-024-00349-z.
4
Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis.腐胺修饰的过氧化氢酶在家族性肌萎缩侧索硬化转基因小鼠模型中的治疗益处。
Exp Neurol. 1999 Sep;159(1):204-16. doi: 10.1006/exnr.1999.7142.
5
Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis.用 Trichostatin A 治疗疾病发作后,可延迟肌萎缩性侧索硬化症小鼠模型的疾病进展并提高存活率。
Exp Neurol. 2011 Sep;231(1):147-59. doi: 10.1016/j.expneurol.2011.06.003. Epub 2011 Jun 25.
6
Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model.肌萎缩侧索硬化小鼠模型中骨骼肌的基因谱分析。
Physiol Genomics. 2008 Jan 17;32(2):207-18. doi: 10.1152/physiolgenomics.00017.2007. Epub 2007 Nov 13.
7
Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis.锰超氧化物歧化酶部分缺乏会加重肌萎缩侧索硬化症的转基因小鼠模型症状。
Ann Neurol. 2000 Apr;47(4):447-55.
8
Calcitonin gene-related peptide expression levels predict motor neuron vulnerability in the superoxide dismutase 1-G93A mouse model of amyotrophic lateral sclerosis.降钙素基因相关肽表达水平预测超氧化物歧化酶 1-G93A 肌萎缩侧索硬化症小鼠模型中运动神经元的易损性。
Neurobiol Dis. 2012 Jan;45(1):547-54. doi: 10.1016/j.nbd.2011.09.011. Epub 2011 Sep 21.
9
A systematic study of brainstem motor nuclei in a mouse model of ALS, the effects of lithium.在肌萎缩侧索硬化症(ALS)的小鼠模型中对脑干运动核进行系统研究,锂的影响。
Neurobiol Dis. 2010 Feb;37(2):370-83. doi: 10.1016/j.nbd.2009.10.017. Epub 2009 Oct 27.
10
In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.通过T2弛豫时间和表观扩散系数对肌萎缩侧索硬化症G93A-SOD1转基因小鼠模型中脊髓和延髓运动神经元变性进行体内定量分析。
Exp Neurol. 2006 Oct;201(2):293-300. doi: 10.1016/j.expneurol.2006.04.007. Epub 2006 Jun 5.

引用本文的文献

1
Schwann Cells in Neuromuscular Disorders: A Spotlight on Amyotrophic Lateral Sclerosis.神经肌肉疾病中的施万细胞:聚焦肌萎缩侧索硬化症
Cells. 2025 Jan 3;14(1):47. doi: 10.3390/cells14010047.
2
SERCA1 Overexpression in Skeletal Muscle Attenuates Muscle Atrophy and Improves Motor Function in a Mouse Model of ALS.在肌萎缩侧索硬化症小鼠模型中,骨骼肌中肌浆网Ca2+-ATP酶1过表达可减轻肌肉萎缩并改善运动功能。
J Neuromuscul Dis. 2024;11(2):315-326. doi: 10.3233/JND-230123.
3
Targeting mitochondrial Ca uptake for the treatment of amyotrophic lateral sclerosis.
靶向线粒体钙摄取治疗肌萎缩侧索硬化症。
J Physiol. 2024 Apr;602(8):1519-1549. doi: 10.1113/JP284143. Epub 2023 Nov 27.
4
Evidence of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis (ALS) Patients and Animal Models.肌萎缩侧索硬化症(ALS)患者和动物模型的代谢功能障碍证据。
Biomolecules. 2023 May 19;13(5):863. doi: 10.3390/biom13050863.
5
Neuroimaging findings in preclinical amyotrophic lateral sclerosis models-How well do they mimic the clinical phenotype? A systematic review.临床前肌萎缩侧索硬化模型的神经影像学研究结果——它们对临床表型的模拟效果如何?一项系统综述。
Front Vet Sci. 2023 May 2;10:1135282. doi: 10.3389/fvets.2023.1135282. eCollection 2023.
6
MiR-146a in ALS: Contribution to Early Peripheral Nerve Degeneration and Relevance as Disease Biomarker.miR-146a 在肌萎缩侧索硬化症中的作用:对早期周围神经退行性变的贡献及作为疾病生物标志物的相关性。
Int J Mol Sci. 2023 Feb 27;24(5):4610. doi: 10.3390/ijms24054610.
7
Integrative genetic and single cell RNA sequencing analysis provides new clues to the amyotrophic lateral sclerosis neurodegeneration.综合基因和单细胞RNA测序分析为肌萎缩侧索硬化症神经变性提供了新线索。
Front Neurosci. 2023 Feb 17;17:1116087. doi: 10.3389/fnins.2023.1116087. eCollection 2023.
8
Honokiol alleviated neurodegeneration by reducing oxidative stress and improving mitochondrial function in mutant SOD1 cellular and mouse models of amyotrophic lateral sclerosis.厚朴酚通过减轻氧化应激和改善线粒体功能,在肌萎缩侧索硬化症的突变型SOD1细胞和小鼠模型中减轻神经退行性变。
Acta Pharm Sin B. 2023 Feb;13(2):577-597. doi: 10.1016/j.apsb.2022.07.019. Epub 2022 Aug 10.
9
Silk fibroin microgels as a platform for cell microencapsulation.丝素蛋白微凝胶作为细胞微囊化的平台。
J Mater Sci Mater Med. 2022 Dec 31;34(1):3. doi: 10.1007/s10856-022-06706-y.
10
Methodological standards, quality of reporting and regulatory compliance in animal research on amyotrophic lateral sclerosis: a systematic review.肌萎缩侧索硬化症动物研究中的方法学标准、报告质量及法规遵循情况:一项系统综述
BMJ Open Sci. 2019 Aug 1;3(1):e000016. doi: 10.1136/bmjos-2018-000016. eCollection 2019.